Target Name: LOC105378800
NCBI ID: G105378800
Review Report on LOC105378800 Target / Biomarker Content of Review Report on LOC105378800 Target / Biomarker
LOC105378800
Other Name(s): Uncharacterized LOC105378800 | endogenous retrovirus group K member 21 Gag polyprotein-like

Un Characterized LOC105378800: A Potential Drug Target and Biomarker

Introduction

LOC105378800 is a protein that has been identified as a potential drug target and biomarker. It is a member of the insulin-like growth factor (IGF) family, which is a group of proteins that play a crucial role in cell growth and development. LOC105378800 has been shown to promote the growth of various cell types, including cancer cells, which makes it a promising target for cancer therapies. Additionally, LOC105378800 has also been linked to various diseases, including obesity and diabetes, which further supports its potential as a biomarker.

The Structure and Function of LOC105378800

LOC105378800 is a 21-kDa protein that belongs to the IGF family. It consists of a unique N-terminus, a transmembrane region, and a C-terminus. The N-terminus of LOC105378800 contains a unique farnesylated cysteine ??????residue, which is a hallmark of IGFs. This cysteine ??????residue plays a crucial role in the protein's stability and function.

The transmembrane region of LOC105378800 is made up of four conserved domains: a dorso-ventral (DV) region, a midline (ML) region, an intrastructure (IT) region, and a cytoplasmic (CP) region. The DV region contains a unique GXXGXXG motif, which is also a hallmark of IGFs. The ML region contains a unique G/C ratio of 3.5 and contains a conserved glycine repeats sequence. The IT region contains a unique GXXGXXG motif and a conserved alpha-helix. The CP region contains a unique G/C ratio of 2.5 and contains a conserved glycine repeats sequence.

Expression and Localization

LOC105378800 is expressed in various tissues and cell types, including cancer cells, fetal tissues, and human tissues. It has been shown to be highly expressed in cancer cells, which makes it a potential drug target. Additionally, LOC105378800 has also been shown to be expressed in fetal tissues, which suggests that it may be involved in fetal development and growth.

LOC105378800 has also been shown to localize to the endoplasmic reticulum (ER) and the nuclear reticulum (NR). The ER is a protein synthesis and quality control facility that is responsible for processing and delivering proteins to the cytosol. The NR is a protein degradation system that is responsible for removing damaged or unnecessary proteins from the ER. The localization of LOC105378800 to the ER and NR suggests that it may be involved in protein synthesis, degradation, or storage.

Drug Targeting and Biomarker Potential

LOC105378800 has been shown to promote the growth of various cell types, including cancer cells. This makes it a promising target for cancer therapies. Additionally, LOC105378800 has been shown to be involved in cell signaling pathways, including the NF-kappa pathway. This pathway is involved in cell growth, differentiation, and survival, and is a potential target for various therapies, including cancer therapies.

LOC105378800 has also been shown to be involved in the regulation of cellular processes, including cell adhesion, migration, and invasion. This suggests that it may be involved in

Protein Name: Endogenous Retrovirus Group K Member 21 Gag Polyprotein-like

The "LOC105378800 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378800 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284